Showing results (181-190 of 280) with videos related to

Sort By:
Pageof 28
European Journal of Gastroenterology & Hepatology|March 9, 2016
Effectiveness of hepatitis B rapid tests toward linkage-to-care: results of a randomized, multicenter studyJulie Bottero, Anders Boyd, Joël Gozlan, et al.
JHEP Reports : Innovation in Hepatology|June 18, 2021
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCVThierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, et al.
Frontiers in Pediatrics|November 13, 2023
SARS-CoV-2 seroprevalence in French 9-year-old children and their parents after the first lockdown in 2020Marie Aline Charles, Pierre-Yves Ancel, Thierry Simeon, et al.
JHEP Reports : Innovation in Hepatology|April 8, 2026
Comparative evaluation of regression and machine-learning models for hepatocellular carcinoma risk stratification across diverse aetiologiesPierre Nahon, Richard Layese, Pierre-André Natella, et al.
Psychological Medicine|October 14, 2024
SARS-CoV-2 infection and the risk of depressive symptoms: a retrospective longitudinal study from the population-based CONSTANCES cohortBaptiste Pignon, Emmanuel Wiernik, Brigitte Ranque, et al.
Hepatology International|August 4, 2022
Diversity of the nucleic acid forms of circulating HBV in chronically infected patients and its impact on viral cycleJules Sotty, Pierre Bablon, Bouchra Lekbaby, et al.
Lancet (London, England)|October 20, 2009
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort studyLaurent Beaugerie, Nicole Brousse, Anne Marie Bouvier, et al.
Scientific Reports|March 24, 2023
ABO blood types and SARS-CoV-2 infection assessed using seroprevalence data in a large population-based sample: the SAPRIS-SERO multi-cohort studyMélanie Deschasaux-Tanguy, Fabien Szabo de Edelenyi, Nathalie Druesne-Pecollo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 14, 2021
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort)Melina Santos, Camelia Protopopescu, Elizabeth Delarocque-Astagneau, et al.
Pageof 28